OBJECTIVE: To determine how routine inpatient provider-initiated HIV testing differs from traditional community-based client-initiated testing with respect to clinical characteristics of children identified and outcomes of outpatient HIV care. DESIGN: Prospective observational cohort. METHODS: Routine clinical data were collected from children identified as HIV-infected by either testing modality in Lilongwe, Malawi, in 2008. After 1 year of outpatient HIV care at the Baylor College of Medicine Clinical Center of Excellence, outcomes were assessed. RESULTS: Of 742 newly identified HIV-infected children enrolling into outpatient HIV care, 20.9% were identified by routine inpatient HIV testing. Compared with community-identified children, hospital-identified patients were younger (median 25.0 vs 53.5 months), with more severe disease (22.2% vs 7.8% WHO stage IV). Of 466 children with known outcomes, 15.0% died within the first year of HIV care; median time to death was 15.0 weeks for community-identified children vs 6.0 weeks for hospital-identified children. The strongest predictors of early mortality were severe malnutrition (hazard ratio, 4.3; 95% confidence interval, 2.2-8.3), moderate malnutrition (hazard ratio, 3.2; confidence interval, 1.6-6.6), age < 12 months (hazard ratio, 3.2; 95% confidence interval, 1.4-7.2), age 12 to 24 months (hazard ratio, 2.5; 95% confidence interval, 1.1-5.7), and WHO stage IV (hazard ratio, 2.2; 95% confidence interval, 1.1-4.6). After controlling for other variables, hospital identification did not independently predict mortality. CONCLUSIONS: Routine inpatient HIV testing identifies a subset of younger HIV-infected children with more severe, rapidly progressing disease that traditional community-based testing modalities are currently missing.
OBJECTIVE: To determine how routine inpatient provider-initiated HIV testing differs from traditional community-based client-initiated testing with respect to clinical characteristics of children identified and outcomes of outpatientHIV care. DESIGN: Prospective observational cohort. METHODS: Routine clinical data were collected from children identified as HIV-infected by either testing modality in Lilongwe, Malawi, in 2008. After 1 year of outpatientHIV care at the Baylor College of Medicine Clinical Center of Excellence, outcomes were assessed. RESULTS: Of 742 newly identified HIV-infectedchildren enrolling into outpatientHIV care, 20.9% were identified by routine inpatient HIV testing. Compared with community-identified children, hospital-identified patients were younger (median 25.0 vs 53.5 months), with more severe disease (22.2% vs 7.8% WHO stage IV). Of 466 children with known outcomes, 15.0% died within the first year of HIV care; median time to death was 15.0 weeks for community-identified children vs 6.0 weeks for hospital-identified children. The strongest predictors of early mortality were severe malnutrition (hazard ratio, 4.3; 95% confidence interval, 2.2-8.3), moderate malnutrition (hazard ratio, 3.2; confidence interval, 1.6-6.6), age < 12 months (hazard ratio, 3.2; 95% confidence interval, 1.4-7.2), age 12 to 24 months (hazard ratio, 2.5; 95% confidence interval, 1.1-5.7), and WHO stage IV (hazard ratio, 2.2; 95% confidence interval, 1.1-4.6). After controlling for other variables, hospital identification did not independently predict mortality. CONCLUSIONS: Routine inpatient HIV testing identifies a subset of younger HIV-infectedchildren with more severe, rapidly progressing disease that traditional community-based testing modalities are currently missing.
Authors: Shirin Heidari; Lynne M Mofenson; Charlotte V Hobbs; Mark F Cotton; Richard Marlink; Elly Katabira Journal: J Acquir Immune Defic Syndr Date: 2012-02-01 Impact factor: 3.731
Authors: Bradley C Fetzer; Mina C Hosseinipour; Portia Kamthuzi; Lisa Hyde; Brian Bramson; Kebba Jobarteh; Kristine Torjesen; William C Miller; Irving Hoffman; Peter Kazembe; Charles Mwansambo Journal: Trop Med Int Health Date: 2009-06-28 Impact factor: 2.622
Authors: E Halapi; T Leitner; M Jansson; G Scarlatti; P Orlandi; A Plebani; L Romiti; J Albert; H Wigzell; P Rossi Journal: AIDS Date: 1997-11-15 Impact factor: 4.177
Authors: Diana S Pope; Andrea N Deluca; Paula Kali; Harry Hausler; Carol Sheard; Ebrahim Hoosain; Mohammad A Chaudhary; David D Celentano; Richard E Chaisson Journal: J Acquir Immune Defic Syndr Date: 2008-06-01 Impact factor: 3.731
Authors: Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre Journal: N Engl J Med Date: 2008-11-20 Impact factor: 91.245
Authors: Eric D McCollum; Geoffrey A Preidis; Madalitso Maliwichi; Dan Olson; L Madeline McCrary; Peter N Kazembe; Charles van der Horst; Irving Hoffman; Mina C Hosseinipour Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: James M Fox; Robert Newton; Marija Bedaj; Ada Keding; Elizabeth Molyneux; Lucy M Carpenter; Fabiola Martin; Nora Mutalima Journal: Trop Med Int Health Date: 2015-02-06 Impact factor: 2.622
Authors: Saeed Ahmed; Maria H Kim; Amanda C Dave; Rachael Sabelli; Kondwani Kanjelo; Geoffrey A Preidis; Thomas P Giordano; Elizabeth Chiao; Mina Hosseinipour; Peter N Kazembe; Frank Chimbwandira; Elaine J Abrams Journal: J Int AIDS Soc Date: 2015-01-07 Impact factor: 5.396
Authors: Chris A Rees; Robert J Flick; David Sullivan; Menard Bvumbwe; Joseph Mhango; Mina C Hosseinipour; Peter N Kazembe Journal: PLoS One Date: 2017-01-18 Impact factor: 3.240
Authors: Brianna L Smith; Sara Zizzo; Anouk Amzel; Sarah Wiant; Molly C Pezzulo; Sarah Konopka; Rachel Golin; Alexandra C Vrazo Journal: Int J MCH AIDS Date: 2018